COVID-19 Vaccines and T1D: Answering Your Questions
UPDATED 2 August 2021
Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated.
With vaccines now being offered to people with T1D, we’ve gathered all the information you need to know below.
When can I get vaccinated?
Adults with diabetes and children aged over 12 with diabetes are included as priority groups in Phase Ib of the COVID-19 National Rollout Strategy in Australia. Vaccinations are currently being offered to those eligible for Phase Ib. You can check your eligibility and book a vaccination appointment here.
Where can I get a vaccine?
Vaccinations are being offered at GP clinics, Aboriginal Community Controlled Health Services, Commonwealth Vaccination clinics and state and territory vaccination clinics. You can find a list of clinics offering vaccination here.
Can children with T1D be vaccinated?
The Therapeutic Goods Administration (TGA) approved the use of the Pfizer COVID-19 vaccine for children aged 12-15 on 23 July 2021.
The Australian Technical Advisory Group on Immunisation (ATAGI) have since announced that children with diabetes will be automatically included in Phase Ib of the national rollout. This means that children with diabetes aged 12 and over are eligible to book a vaccination now.
What about children under 12?
Clinical trials of the Pfizer vaccine in children under 12 are underway. However, it is likely to be several more months before this data is submitted to the TGA and a decision is made whether to expand eligibility to this age group.
Are COVID-19 vaccines safe for people with T1D?
The vaccines available in Australia are safe, and there is no evidence that people with T1D respond any differently to the rest of the population.
All vaccines are thoroughly assessed for safety before they are approved for use in Australia, and safety will continue to be monitored and reassessed during the vaccine rollout.
Is it safe for elderly people with T1D to get vaccinated?
The vaccines are safe to use for elderly people with T1D. In clinical trials, the vaccines were tested in people up to age 90, including some with diabetes. Millions of people in aged care facilities overseas have already been vaccinated.
For frail older people, or those aged over 85, the benefits and risks of vaccination should be discussed with a healthcare professional. The Department of Health has information on decision making here.
Will there be any side effects?
Based on experiences overseas, most of the side effects from the Pfizer and AstraZeneca vaccines are mild. You might experience a sore arm or redness, feel tired or have a mild fever. These side effects are a normal response to vaccination and should go away in a few days.
What about the AstraZeneca vaccine and blood clotting?
Thrombosis with thrombocytopenia syndrome (TTS) is a very rare side effect of the AstraZeneca vaccine. It is different from other types of blood clot, like deep vein thrombosis, and there is no evidence that people with type 1 diabetes are at a higher risk of developing TTS.
For the latest advice on the AstraZeneca vaccine, visit the Department of Health website.
What about my blood sugar levels?
Some people with T1D experience a temporary impact on blood sugar levels after receiving a vaccine. Check your levels frequently in the 48 hours after being vaccinated, stay hydrated, and familiarise yourself with your sick day plan.
If you have concerns about any potential side effects, it’s best to talk to your healthcare team.
Can I get COVID-19 from a vaccine?
No, you cannot get COVID-19 from receiving a vaccine.
Do I have to get vaccinated?
COVID-19 vaccination is voluntary, but strongly encouraged for all Australians. If you’re hesitant about getting vaccinated, we recommend talking to your healthcare team about your concerns and asking questions to help you make an informed decision.
JDRF welcomes senior business leader Ian Narev to the JDRF Board
Mr Narev will bring more than 30 years of strategy and leadership experience garnered across consulting finance and technology businesses. JDRF Australia are delighted to welcome Ian Narev, Managing Director and Chief Executive Officer of SEEK to the Board. Mr Narev, who joined the Board at the September 2021 Board meeting, is no stranger to JDRF having spent several years as co-Chair of the JDRF Australia Advisory Board. Alongside his historical […]
Meet the inspiring father-daughter duo taking on the JDRF One Ride Challenge!
Let’s meet the inspiring father-daughter duo who share a passion for BMX riding and a goal to help defeat type 1 diabetes. Daniel was diagnosed with type 1 diabetes (T1D) at a young age, but that didn’t stop him from becoming a proud father of two, a motorcycle racer, and a mentor and supporter to […]
JDRF launches pilot study of general population screening for type 1 diabetes
Last year, JDRF appointed Dr Kirstine Bell from the Charles Perkins Centre, University of Sydney, to lead a pilot study to screen for risk of type 1 diabetes in the general population. Today, Dr Bell launched the national screening project and revealed new details about what it will involve. “Children are often diagnosed with type […]
COVID-19 Vaccines and T1D: Answering Your Questions
UPDATED 2 August 2021 Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines now being offered to people with T1D, we’ve gathered all the information […]